Latest News and Press Releases
Want to stay updated on the latest news?
-
New York, United States, Jan. 19, 2023 (GLOBE NEWSWIRE) -- A switchgear is a mechanical tool used to control, protect, and turn on and off electrical equipment. It consists of fuses, circuit...
-
New York, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Downhole Tools Global Market Report 2022: Ukraine-Russia War Impact" -...
-
New York, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Downhole Tools Global Market Report 2022: Ukraine-Russia War Impact" -...
-
SAN DIEGO, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on small-molecule...
-
LTBP1 is key regulator of TGF-β, a major driver of fibrosis. Latest target identified from company’s platform in collaboration with Dualsystems Biotech AG. SAN DIEGO, Dec. 15, 2022 (GLOBE...
-
Replay targets genetic brain disorders with new gene therapy company, Kaleibe, utilising big DNA HSV technology Third product company from Replay expands use of next-generation high payload...
-
USA, Dec. 10, 2022 (GLOBE NEWSWIRE) -- “Global Next Generation Sequencing Маrkеt” іѕ thе tіtlе оf а rесеntlу рublіѕhеd rероrt bу JCMR market research. Тhе rеѕеаrсh ѕtudу іnvоlvеd ехреrt оріnіоn and...
-
Dublin, Nov. 16, 2022 (GLOBE NEWSWIRE) -- The "The Market for RNA Sequencing, 2nd Edition" report has been added to ResearchAndMarkets.com's offering. This report focuses on the market for RNA...
-
SAN DIEGO, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on small-molecule...
-
Boston, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Duck Creek Technologies (NASDAQ: DCT), the intelligent solutions provider defining the future of property and casualty (P&C) insurance, is thrilled to...